Eucalyptus (Herb/Suppl)

Brand and Other Names:fevertree, gum tree, more...red ironbark, white ironbark
  • Print

Suggested Dosing

Oil

Arthritis: 5-20% in an oil-based formulation or 5-10% in an alcohol-based formulation

Nasal Congestion: 1 tsp in boiling water for steam inhalation; also rub on chest & around nose

Next:

Suggested Uses

Arthritis, nasal congestion, asthma, skin ulcers, tick repellant

Previous
Next:

Interactions

Interaction Checker

and Eucalyptus

No Results

     activity indicator 
    No Interactions Found
    Interactions Found

    Contraindicated

      Serious - Use Alternative

        Significant - Monitor Closely

          Minor

            All Interactions Sort By:
             activity indicator 

            Contraindicated (0)

              Serious - Use Alternative (0)

                Monitor Closely (14)

                • carbamazepine

                  carbamazepine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • cimetidine

                  cimetidine will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • clarithromycin

                  clarithromycin will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • erythromycin base

                  erythromycin base will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • erythromycin ethylsuccinate

                  erythromycin ethylsuccinate will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • erythromycin lactobionate

                  erythromycin lactobionate will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • erythromycin stearate

                  erythromycin stearate will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • fluorouracil

                  eucalyptus increases levels of fluorouracil by Other (see comment). Use Caution/Monitor. Comment: Applies to topical preparations only. Mechanism: enhanced transdermal absorption.

                • ketoconazole

                  ketoconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • levoketoconazole

                  levoketoconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • rifabutin

                  rifabutin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • rifampin

                  rifampin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • St John's Wort

                  St John's Wort will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Monitor.

                • topiramate

                  eucalyptus and topiramate both increase sedation. Use Caution/Monitor.

                Minor (236)

                • acarbose

                  eucalyptus increases effects of acarbose by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • albuterol

                  eucalyptus increases and albuterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • alfentanil

                  alfentanil and eucalyptus both increase sedation. Minor/Significance Unknown.

                • alprazolam

                  alprazolam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • amitriptyline

                  amitriptyline and eucalyptus both increase sedation. Minor/Significance Unknown.

                • amobarbital

                  amobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  amobarbital and eucalyptus both increase sedation. Minor/Significance Unknown.

                • amoxapine

                  amoxapine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • apomorphine

                  apomorphine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • aprepitant

                  aprepitant will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • arformoterol

                  eucalyptus increases and arformoterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • aripiprazole

                  aripiprazole and eucalyptus both increase sedation. Minor/Significance Unknown.

                • armodafinil

                  armodafinil will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  eucalyptus increases and armodafinil decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • artemether/lumefantrine

                  artemether/lumefantrine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • atazanavir

                  atazanavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • azelastine

                  azelastine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • baclofen

                  baclofen and eucalyptus both increase sedation. Minor/Significance Unknown.

                • belladonna and opium

                  belladonna and opium and eucalyptus both increase sedation. Minor/Significance Unknown.

                • benperidol

                  benperidol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • benzphetamine

                  eucalyptus increases and benzphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • bosentan

                  bosentan will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • brompheniramine

                  brompheniramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • budesonide

                  budesonide will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • buprenorphine

                  buprenorphine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • buprenorphine buccal

                  buprenorphine buccal and eucalyptus both increase sedation. Minor/Significance Unknown.

                • butabarbital

                  butabarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  butabarbital and eucalyptus both increase sedation. Minor/Significance Unknown.

                • butalbital

                  butalbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  butalbital and eucalyptus both increase sedation. Minor/Significance Unknown.

                • butorphanol

                  butorphanol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • caffeine

                  eucalyptus increases and caffeine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • calcium/magnesium/potassium/sodium oxybates

                  eucalyptus and calcium/magnesium/potassium/sodium oxybates both increase sedation. Minor/Significance Unknown.

                • carbinoxamine

                  carbinoxamine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • carisoprodol

                  carisoprodol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • chloral hydrate

                  chloral hydrate and eucalyptus both increase sedation. Minor/Significance Unknown.

                • chlordiazepoxide

                  chlordiazepoxide and eucalyptus both increase sedation. Minor/Significance Unknown.

                • chlorpheniramine

                  chlorpheniramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • chlorpromazine

                  chlorpromazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • chlorpropamide

                  eucalyptus increases effects of chlorpropamide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • chlorzoxazone

                  chlorzoxazone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • cinnarizine

                  cinnarizine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • clemastine

                  clemastine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • clomipramine

                  clomipramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • clonazepam

                  clonazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • clorazepate

                  clorazepate and eucalyptus both increase sedation. Minor/Significance Unknown.

                • clozapine

                  clozapine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • codeine

                  codeine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • conivaptan

                  conivaptan will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • cortisone

                  cortisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • cyclizine

                  cyclizine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • cyclobenzaprine

                  cyclobenzaprine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • cyclosporine

                  cyclosporine will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • cyproheptadine

                  cyproheptadine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dantrolene

                  dantrolene and eucalyptus both increase sedation. Minor/Significance Unknown.

                • darifenacin

                  darifenacin will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • darunavir

                  darunavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • dasatinib

                  dasatinib will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • desipramine

                  desipramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dexamethasone

                  dexamethasone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • dexchlorpheniramine

                  dexchlorpheniramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dexfenfluramine

                  eucalyptus increases and dexfenfluramine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • dexmedetomidine

                  dexmedetomidine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dexmethylphenidate

                  eucalyptus increases and dexmethylphenidate decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • dextroamphetamine

                  eucalyptus increases and dextroamphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • dextromoramide

                  dextromoramide and eucalyptus both increase sedation. Minor/Significance Unknown.

                • DHEA, herbal

                  DHEA, herbal will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • diamorphine

                  diamorphine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • diazepam

                  diazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • diethylpropion

                  eucalyptus increases and diethylpropion decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • difenoxin hcl

                  difenoxin hcl and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dimenhydrinate

                  dimenhydrinate and eucalyptus both increase sedation. Minor/Significance Unknown.

                • diphenhydramine

                  diphenhydramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • diphenoxylate hcl

                  diphenoxylate hcl and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dipipanone

                  dipipanone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dobutamine

                  eucalyptus increases and dobutamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • dopamine

                  eucalyptus increases and dopamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • dopexamine

                  eucalyptus increases and dopexamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • doxepin

                  doxepin and eucalyptus both increase sedation. Minor/Significance Unknown.

                • doxylamine

                  doxylamine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • dronedarone

                  dronedarone will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • droperidol

                  droperidol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • efavirenz

                  efavirenz will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • ephedrine

                  eucalyptus increases and ephedrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • epinephrine

                  eucalyptus increases and epinephrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • epinephrine racemic

                  eucalyptus increases and epinephrine racemic decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • eslicarbazepine acetate

                  eslicarbazepine acetate will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • estazolam

                  estazolam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • ethanol

                  ethanol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • etomidate

                  etomidate and eucalyptus both increase sedation. Minor/Significance Unknown.

                • etravirine

                  etravirine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • fenfluramine

                  eucalyptus increases and fenfluramine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • fluconazole

                  fluconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • fludrocortisone

                  fludrocortisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • fluphenazine

                  fluphenazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • flurazepam

                  flurazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • formoterol

                  eucalyptus increases and formoterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • fosamprenavir

                  fosamprenavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • fosphenytoin

                  fosphenytoin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • glimepiride

                  eucalyptus increases effects of glimepiride by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • glipizide

                  eucalyptus increases effects of glipizide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • glyburide

                  eucalyptus increases effects of glyburide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • grapefruit

                  grapefruit will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • griseofulvin

                  griseofulvin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • haloperidol

                  haloperidol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • hydrocortisone

                  hydrocortisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • hydromorphone

                  hydromorphone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • hydroxyzine

                  hydroxyzine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • iloperidone

                  iloperidone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • imipramine

                  imipramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • indinavir

                  indinavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • insulin aspart

                  eucalyptus increases effects of insulin aspart by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • insulin detemir

                  eucalyptus increases effects of insulin detemir by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • insulin glargine

                  eucalyptus increases effects of insulin glargine by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • insulin glulisine

                  eucalyptus increases effects of insulin glulisine by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • insulin lispro

                  eucalyptus increases effects of insulin lispro by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • insulin NPH

                  eucalyptus increases effects of insulin NPH by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • insulin regular human

                  eucalyptus increases effects of insulin regular human by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • isoniazid

                  isoniazid will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • isoproterenol

                  eucalyptus increases and isoproterenol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • ketotifen, ophthalmic

                  eucalyptus and ketotifen, ophthalmic both increase sedation. Minor/Significance Unknown.

                • lapatinib

                  lapatinib will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • levalbuterol

                  eucalyptus increases and levalbuterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • levoketoconazole

                  eucalyptus will decrease the level or effect of levoketoconazole by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • levorphanol

                  levorphanol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • lisdexamfetamine

                  eucalyptus increases and lisdexamfetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • lofepramine

                  lofepramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • lofexidine

                  eucalyptus and lofexidine both increase sedation. Minor/Significance Unknown.

                • loprazolam

                  loprazolam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • lorazepam

                  lorazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • lormetazepam

                  lormetazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • loxapine

                  loxapine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • loxapine inhaled

                  loxapine inhaled and eucalyptus both increase sedation. Minor/Significance Unknown.

                • lumefantrine

                  lumefantrine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • maprotiline

                  maprotiline and eucalyptus both increase sedation. Minor/Significance Unknown.

                • marijuana

                  marijuana will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  eucalyptus and marijuana both increase sedation. Minor/Significance Unknown.

                • melatonin

                  eucalyptus and melatonin both increase sedation. Minor/Significance Unknown.

                • meperidine

                  meperidine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • meprobamate

                  eucalyptus and meprobamate both increase sedation. Minor/Significance Unknown.

                • metaproterenol

                  eucalyptus increases and metaproterenol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • metaxalone

                  metaxalone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • metformin

                  eucalyptus increases effects of metformin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • methadone

                  methadone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • methamphetamine

                  eucalyptus increases and methamphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • methocarbamol

                  methocarbamol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • methylenedioxymethamphetamine

                  eucalyptus increases and methylenedioxymethamphetamine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • methylprednisolone

                  methylprednisolone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • metronidazole

                  metronidazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • miconazole vaginal

                  miconazole vaginal will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • midazolam

                  midazolam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • midodrine

                  eucalyptus increases and midodrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • miglitol

                  eucalyptus increases effects of miglitol by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • mirtazapine

                  eucalyptus and mirtazapine both increase sedation. Minor/Significance Unknown.

                • modafinil

                  eucalyptus increases and modafinil decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • morphine

                  morphine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • motherwort

                  eucalyptus and motherwort both increase sedation. Minor/Significance Unknown.

                • moxonidine

                  eucalyptus and moxonidine both increase sedation. Minor/Significance Unknown.

                • nabilone

                  eucalyptus and nabilone both increase sedation. Minor/Significance Unknown.

                • nafcillin

                  nafcillin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • nalbuphine

                  nalbuphine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • nateglinide

                  eucalyptus increases effects of nateglinide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • nefazodone

                  nefazodone will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • nelfinavir

                  nelfinavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • nevirapine

                  nevirapine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • nifedipine

                  nifedipine will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • nilotinib

                  nilotinib will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • norepinephrine

                  eucalyptus increases and norepinephrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • nortriptyline

                  nortriptyline and eucalyptus both increase sedation. Minor/Significance Unknown.

                • olanzapine

                  olanzapine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • opium tincture

                  opium tincture and eucalyptus both increase sedation. Minor/Significance Unknown.

                • orphenadrine

                  orphenadrine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • oxazepam

                  oxazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • oxcarbazepine

                  oxcarbazepine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • oxycodone

                  oxycodone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • oxymorphone

                  oxymorphone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • paliperidone

                  paliperidone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • papaveretum

                  papaveretum and eucalyptus both increase sedation. Minor/Significance Unknown.

                • papaverine

                  eucalyptus and papaverine both increase sedation. Minor/Significance Unknown.

                • pentazocine

                  pentazocine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • pentobarbital

                  pentobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  pentobarbital and eucalyptus both increase sedation. Minor/Significance Unknown.

                • perphenazine

                  perphenazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • phendimetrazine

                  eucalyptus increases and phendimetrazine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • phenobarbital

                  phenobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  phenobarbital and eucalyptus both increase sedation. Minor/Significance Unknown.

                • phentermine

                  eucalyptus increases and phentermine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • phenylephrine

                  eucalyptus increases and phenylephrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • phenylephrine PO

                  eucalyptus increases and phenylephrine PO decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown. .

                • phenytoin

                  phenytoin will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • pholcodine

                  eucalyptus and pholcodine both increase sedation. Minor/Significance Unknown.

                • pimozide

                  pimozide and eucalyptus both increase sedation. Minor/Significance Unknown.

                • pioglitazone

                  eucalyptus increases effects of pioglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • pirbuterol

                  eucalyptus increases and pirbuterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • posaconazole

                  posaconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • prednisone

                  prednisone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • primidone

                  primidone will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  primidone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • prochlorperazine

                  prochlorperazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • promethazine

                  promethazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • propylhexedrine

                  eucalyptus increases and propylhexedrine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • protriptyline

                  protriptyline and eucalyptus both increase sedation. Minor/Significance Unknown.

                • quazepam

                  quazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • quetiapine

                  quetiapine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • quinupristin/dalfopristin

                  quinupristin/dalfopristin will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • ramelteon

                  eucalyptus and ramelteon both increase sedation. Minor/Significance Unknown.

                • repaglinide

                  eucalyptus increases effects of repaglinide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • rifapentine

                  rifapentine will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • risperidone

                  risperidone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • ritonavir

                  ritonavir will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • rosiglitazone

                  eucalyptus increases effects of rosiglitazone by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • rufinamide

                  rufinamide will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • sage

                  eucalyptus and sage both increase sedation. Minor/Significance Unknown.

                • salmeterol

                  eucalyptus increases and salmeterol decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • saxagliptin

                  eucalyptus increases effects of saxagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • scullcap

                  eucalyptus and scullcap both increase sedation. Minor/Significance Unknown.

                • secobarbital

                  secobarbital will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                  secobarbital and eucalyptus both increase sedation. Minor/Significance Unknown.

                • shepherd's purse

                  eucalyptus and shepherd's purse both increase sedation. Minor/Significance Unknown.

                • sitagliptin

                  eucalyptus increases effects of sitagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • sodium oxybate

                  eucalyptus and sodium oxybate both increase sedation. Minor/Significance Unknown.

                • sufentanil

                  sufentanil and eucalyptus both increase sedation. Minor/Significance Unknown.

                • tapentadol

                  tapentadol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • temazepam

                  temazepam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • terbutaline

                  eucalyptus increases and terbutaline decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • thioridazine

                  thioridazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • thiothixene

                  thiothixene and eucalyptus both increase sedation. Minor/Significance Unknown.

                • tolazamide

                  eucalyptus increases effects of tolazamide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • tolbutamide

                  eucalyptus increases effects of tolbutamide by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • topiramate

                  topiramate will decrease the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • tramadol

                  tramadol and eucalyptus both increase sedation. Minor/Significance Unknown.

                • trazodone

                  trazodone and eucalyptus both increase sedation. Minor/Significance Unknown.

                • triazolam

                  triazolam and eucalyptus both increase sedation. Minor/Significance Unknown.

                • triclofos

                  triclofos and eucalyptus both increase sedation. Minor/Significance Unknown.

                • trifluoperazine

                  trifluoperazine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • trimipramine

                  trimipramine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • triprolidine

                  triprolidine and eucalyptus both increase sedation. Minor/Significance Unknown.

                • verapamil

                  verapamil will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • vildagliptin

                  eucalyptus increases effects of vildagliptin by pharmacodynamic synergism. Minor/Significance Unknown. Theoretical interaction.

                • voriconazole

                  voriconazole will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • xylometazoline

                  eucalyptus increases and xylometazoline decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • yohimbine

                  eucalyptus increases and yohimbine decreases sedation. Effect of interaction is not clear, use caution. Minor/Significance Unknown.

                • zafirlukast

                  zafirlukast will increase the level or effect of eucalyptus by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Minor/Significance Unknown.

                • ziconotide

                  eucalyptus and ziconotide both increase sedation. Minor/Significance Unknown.

                • ziprasidone

                  ziprasidone and eucalyptus both increase sedation. Minor/Significance Unknown.

                Previous
                Next:

                Adverse Effects

                Allergic rxns

                Severe AEs if oil is taken PO: abd pain, cyanosis, dyspnea, ataxia, hypotension, arrhythmias, multiorgan failure

                Previous
                Next:

                Warnings

                Contraindications

                Acute intermittent porphyria

                Cautions

                Do NOT ingest oil - severe, potentially fatal toxicity

                Diabetes, hypoglycemia

                Previous
                Next:

                Pregnancy & Lactation

                Pregnancy Category: avoid

                Lactation: avoid

                Pregnancy Categories

                A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.

                B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.

                C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.

                D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.

                X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.

                NA: Information not available.

                Previous
                Next:

                Pharmacology

                Mechanism of Action

                Elicits anti-inflammatory effect by interacting with OH- radicals; interferes with leukocyte activation

                Previous
                Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.